RAPT Therapeutics earnings beat by $0.01, revenue fell short of estimates

  • Investing.com
RAPT Therapeutics earnings beat by $0.01, revenue fell short of estimates
Credit: © Reuters.

Investing.com - RAPT Therapeutics (NASDAQ: RAPT) reported first quarter EPS of $-0.64, $0.01 better than the analyst estimate of $-0.65. Revenue for the quarter came in at $0.00 versus the consensus estimate of $132.5K.

RAPT Therapeutics's stock price closed at $26.61. It is up 48.74% in the last 3 months and up 24.93% in the last 12 months.

RAPT Therapeutics saw 7 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See RAPT Therapeutics's stock price’s past reactions to earnings here.

According to InvestingPro, RAPT Therapeutics's Financial Health score is "performance".

Check out RAPT Therapeutics's recent earnings performance , and RAPT Therapeutics's financials here.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles